Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.7215-7216 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7216 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 7215 |
| container_title | Blood |
| container_volume | 140 |
| creator | Hammons, Lindsay Haider, Shabi Pasquini, Marcelo C Chhabra, Saurabh Radhakrishnan, Sabarinath Zamora, Anthony E. Mohan, Meera Dong, Jing Janz, Siegfried D'Souza, Anita Hari, Parameswaran Dhakal, Binod |
| description | |
| doi_str_mv | 10.1182/blood-2022-165483 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_165483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122047656</els_id><sourcerecordid>S0006497122047656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1853-7aaef59ecd698ab3bb01049b7167d259a44e6b6b0726b78f8522d470f255519e3</originalsourceid><addsrcrecordid>eNp9kM1u3CAURlHVSp2mfYDuWE4WNICNf5SVY6VJpFiNLHdtYXw9Q8WABTTRvFafMEym66zu4t7zfVcHoe-M_mCs4leTcW4mnHJOWCHyKvuANkzwilDK6Ue0oZQWJK9L9hl9CeEPpSzPuNigf-1eH8BrhRsb9Q4s7kHBGp0nA962TU-GS9yCMXjYg5frEQ_S7yBqu8M3bddgbfGTjBpsDPhFxz1-8tp53BjjUhqk4MFLG1YjbUx3zuKtTDty36Zgfaozcg0wY2nnqwT2sHipUv8Rd39N1KsB3B3BuIPE277vusuv6NMiTYBv_-cF-v3zdmjvyeOvu4e2eSSKVSIjpZSwiBrUXNSVnLJpoozm9VSyopy5qGWeQzEVEy15MZXVUgnO57ykCxdCsBqyC8TOucq7EDws4-r1QfrjyOh4kj6-SR9P0sez9MRcnxlIjz1r8GNQyY2CWXtQcZydfod-BZQFik8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Hammons, Lindsay ; Haider, Shabi ; Pasquini, Marcelo C ; Chhabra, Saurabh ; Radhakrishnan, Sabarinath ; Zamora, Anthony E. ; Mohan, Meera ; Dong, Jing ; Janz, Siegfried ; D'Souza, Anita ; Hari, Parameswaran ; Dhakal, Binod</creator><creatorcontrib>Hammons, Lindsay ; Haider, Shabi ; Pasquini, Marcelo C ; Chhabra, Saurabh ; Radhakrishnan, Sabarinath ; Zamora, Anthony E. ; Mohan, Meera ; Dong, Jing ; Janz, Siegfried ; D'Souza, Anita ; Hari, Parameswaran ; Dhakal, Binod</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-165483</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.7215-7216</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1853-7aaef59ecd698ab3bb01049b7167d259a44e6b6b0726b78f8522d470f255519e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hammons, Lindsay</creatorcontrib><creatorcontrib>Haider, Shabi</creatorcontrib><creatorcontrib>Pasquini, Marcelo C</creatorcontrib><creatorcontrib>Chhabra, Saurabh</creatorcontrib><creatorcontrib>Radhakrishnan, Sabarinath</creatorcontrib><creatorcontrib>Zamora, Anthony E.</creatorcontrib><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Dong, Jing</creatorcontrib><creatorcontrib>Janz, Siegfried</creatorcontrib><creatorcontrib>D'Souza, Anita</creatorcontrib><creatorcontrib>Hari, Parameswaran</creatorcontrib><creatorcontrib>Dhakal, Binod</creatorcontrib><title>Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u3CAURlHVSp2mfYDuWE4WNICNf5SVY6VJpFiNLHdtYXw9Q8WABTTRvFafMEym66zu4t7zfVcHoe-M_mCs4leTcW4mnHJOWCHyKvuANkzwilDK6Ue0oZQWJK9L9hl9CeEPpSzPuNigf-1eH8BrhRsb9Q4s7kHBGp0nA962TU-GS9yCMXjYg5frEQ_S7yBqu8M3bddgbfGTjBpsDPhFxz1-8tp53BjjUhqk4MFLG1YjbUx3zuKtTDty36Zgfaozcg0wY2nnqwT2sHipUv8Rd39N1KsB3B3BuIPE277vusuv6NMiTYBv_-cF-v3zdmjvyeOvu4e2eSSKVSIjpZSwiBrUXNSVnLJpoozm9VSyopy5qGWeQzEVEy15MZXVUgnO57ykCxdCsBqyC8TOucq7EDws4-r1QfrjyOh4kj6-SR9P0sez9MRcnxlIjz1r8GNQyY2CWXtQcZydfod-BZQFik8</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Hammons, Lindsay</creator><creator>Haider, Shabi</creator><creator>Pasquini, Marcelo C</creator><creator>Chhabra, Saurabh</creator><creator>Radhakrishnan, Sabarinath</creator><creator>Zamora, Anthony E.</creator><creator>Mohan, Meera</creator><creator>Dong, Jing</creator><creator>Janz, Siegfried</creator><creator>D'Souza, Anita</creator><creator>Hari, Parameswaran</creator><creator>Dhakal, Binod</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)</title><author>Hammons, Lindsay ; Haider, Shabi ; Pasquini, Marcelo C ; Chhabra, Saurabh ; Radhakrishnan, Sabarinath ; Zamora, Anthony E. ; Mohan, Meera ; Dong, Jing ; Janz, Siegfried ; D'Souza, Anita ; Hari, Parameswaran ; Dhakal, Binod</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1853-7aaef59ecd698ab3bb01049b7167d259a44e6b6b0726b78f8522d470f255519e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammons, Lindsay</creatorcontrib><creatorcontrib>Haider, Shabi</creatorcontrib><creatorcontrib>Pasquini, Marcelo C</creatorcontrib><creatorcontrib>Chhabra, Saurabh</creatorcontrib><creatorcontrib>Radhakrishnan, Sabarinath</creatorcontrib><creatorcontrib>Zamora, Anthony E.</creatorcontrib><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Dong, Jing</creatorcontrib><creatorcontrib>Janz, Siegfried</creatorcontrib><creatorcontrib>D'Souza, Anita</creatorcontrib><creatorcontrib>Hari, Parameswaran</creatorcontrib><creatorcontrib>Dhakal, Binod</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammons, Lindsay</au><au>Haider, Shabi</au><au>Pasquini, Marcelo C</au><au>Chhabra, Saurabh</au><au>Radhakrishnan, Sabarinath</au><au>Zamora, Anthony E.</au><au>Mohan, Meera</au><au>Dong, Jing</au><au>Janz, Siegfried</au><au>D'Souza, Anita</au><au>Hari, Parameswaran</au><au>Dhakal, Binod</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>7215</spage><epage>7216</epage><pages>7215-7216</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-165483</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.7215-7216 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_165483 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T06%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chimeric%20Antigen%20Receptor-T%20(CAR-T)%20Cell%20Therapy%20Targeting%20BCMA%20in%20Patients%20with%20Prior%20Allogeneic%20Transplantation%20(allo-HCT)%20in%20Relapsed%20and/or%20Refractory%20Multiple%20Myeloma%20(RRMM)&rft.jtitle=Blood&rft.au=Hammons,%20Lindsay&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=7215&rft.epage=7216&rft.pages=7215-7216&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-165483&rft_dat=%3Celsevier_cross%3ES0006497122047656%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122047656&rfr_iscdi=true |